Knockdown of MYCN in cell models reactivated the differentiated subtype 1 photoreceptor signature, suggesting a transition between the differentiated subtype 1 retinoblastoma and the more aggressive subtype 2 retinoblastoma that can potentially be reversed via targeting MYCN. This evidence concerns the gene MYCN and retinoblastoma.